FindTrial
Sign In

Admission neutrophil to lymphocyte ratio predicting poor outcome after aneurysmal subarachnoid hemorrhage

Relationship between neutrophil to lymphocyte ratio and outcome after aneurysmal subarachnoid hemorrhage

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056135
Enrollment
Unknown
Registered
2022-02-01
Start date
2020-09-10
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subarachnoid hemorrhage

Interventions

Observation group:None

Sponsors

Second Affiliated Hospital of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with aneurysmal subarachnoid hemorrhage confirmed by CT angiography or digital subtraction angiography who underwent surgery or interventional therapy; 2. Age 18-80 years; 3. Patients who received treatment for ruptured aneurysms within 72 hours; 4. Admission within 24 hours of initial symptoms onset; 5. Initial blood sampling for laboratory test was performed within 24 hours after bleeding.

Exclusion criteria

Exclusion criteria: 1. Patients with acute or chronic infection, cardiovascular and cerebrovascular diseases, hematological diseases, autoimmune diseases, and other systemic diseases (including malignant tumors, uremia, and severe liver and kidney dysfunction); 2. Patients lost follow-up.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale, mRS;—

Countries

China

Contacts

Public ContactYinghan Guo

Second Affiliated Hospital of Zhejiang University

guoyinghan36@163.com+86 17857418596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026